Year 2022 / Volume 114 / Number 5
Editorial
Chronic intestinal failure: an overview and future perspectives

251-253

DOI: 10.17235/reed.2022.8827/2022

Francisco López Romero-Salazar, Pilar Martínez Montiel, Simon Lal,

Abstract
Intestinal failure (IF) is the inability of the gut to absorb necessary water, macronutrients, micronutrients, and electrolytes sufficient to sustain life and requiring intravenous supplementation or replacement. IF Types 1 and 2 are the initial phase of this condition and usually last for weeks to a few months. Type 3 IF (also known as chronic IF [CIF]) is a chronic and stable condition, usually irreversible, whose main treatment is home parenteral nutrition. CIF is a relatively rare condition, and its prevalence and different causes vary throughout the world. Due to its complexity, CIF requires a multidisciplinary team with experience in this field to achieve successful outcomes. This editorial aims to provide an overview of CIF in adults, emphasizing the challenges faced by clinicians when managing this rare entity, as well as outlining the role of the gastroenterologist.
Share Button
New comment
Comments
No comments for this article
References
1. Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr 2015 Apr;34(2):171e80. doi: 10.1016/j.clnu.2014.08.017.
2. Lal S, Teubner A, Shaffer JL. Review article: Intestinal failure. Alimentary Pharmacology and Therapeutics. 2006;24(1):19–31. doi: 10.1111/j.1365-2036.2006.02941.x.
3. Mundi MS, Pattinson A, McMahon MT et al. Prevalence of home parenteral and Enteral Nutrition in the United States. Nutrition in Clinical Practice. 2017;32(6):799–805. doi: 10.1177/0884533617718472.
4. Brandt CF, Hvistendahl M, Naimi RM, et al. Home parenteral nutrition in adult patients with chronic intestinal failure: The evolution over 4 decades in a tertiary referral center. Journal of Parenteral and Enteral Nutrition. 2016;41(7):1178–87. doi: 10.1177/0148607116655449.
5. Smith T, Naghibi M. BANS: Annual BANS Report. Artificial Nutrition Support in the UK 2005-2015. Adult Home Parenteral Nutrition & Home Intravenous Fluids. 2017; [cited 2022Mar14] Available from: https://www.bapen.org.uk/images/pdfs/reports/bans-report-2016.pdf
6. Wanden-Berghe C, Casas N, Compés C, et al. Home and Ambulatory Artificial Nutrition (NADYA) Group report: home parenteral nutrition in Spain, 2019. Nutr Hosp. 2021 Oct 21;38. doi: 10.20960/nh.03720.
7. Jeppesen PB. The Long Road to the development of effective therapies for the short gut syndrome: A personal perspective. Digestive Diseases and Sciences. 2019;64(10):2717–35. doi: 10.1007/s10620-019-05779-0.
8. Diálisis y trasplante [Internet]. Bienvenida | Sociedad Española de Nefrología. [cited 2022Mar16]. Available from: https://www.senefro.org/modules.php?name=webstructure&idwebstructure=29
9. IF treatment and care across Europe [Internet]. ATLAS. [cited 2022 Mar16]. Available from: https://www.atlasif.eu/standard-of-care/if-treatment-and-care-across-europe/
10. Pironi L, Konrad D, Brandt C, et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicentre cross-sectional survey. Clinical Nutrition. 2018;37(2):728-738. doi: 10.1016/j.clnu.2017.04.013.
11. Pironi L, Steiger E, Joly F, et al. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicentre survey. Clin Nutr ESPEN. 2021 Oct;45:433-441. doi: 10.1016/j.clnesp.2021.07.004.
12. Dibb M, Soop M, Teubner A, et al. Survival and nutritional dependence on home parenteral nutrition: Three decades of experience from a single referral centre. Clinical Nutrition. 2017;36(2):570-576. doi: 10.1016/j.clnu.2016.01.028.
13. Rahman A, Jairath V, Feagan B et al. Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort. Alimentary Pharmacology & Therapeutics. 2019;50(10):1086-1093. doi: 10.1111/apt.15511.
14. Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016 Apr 1;35(2):247–307. doi: 10.1016/j.clnu.2016.01.020.
15. Bond A, Teubner A, Taylor M, et al. Assessing the impact of quality improvement measures on catheter related blood stream infections and catheter salvage: Experience from a national intestinal failure unit. Clinical Nutrition. 2018;37(6):2097–101. doi: 10.1016/j.clnu.2017.10.002.
16. Pironi L, Steiger E, Joly F, Wanten GJA, Chambrier C, Aimasso U, et al. Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure. Gut. 2020 Oct 1;69(10):1787–95. doi: 10.1136/gutjnl-2018-318172.
17. Lauro A, Panaro F, Iyer K. An overview of EU and USA intestinal transplant current activity. Journal of Visceral Surgery. 2017;154(2):105-114. doi: 10.1016/j.jviscsurg.2017.01.007.
Citation tools
López Romero-Salazar F, Martínez Montiel P, Lal S. Chronic intestinal failure: an overview and future perspectives. 8827/2022


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 954 visits.
This article has been downloaded 381 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 30/03/2022

Accepted: 30/03/2022

Online First: 04/04/2022

Published: 06/05/2022

Article Online First time: 5 days

Article editing time: 37 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology